Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D, Gene Regulation and Physiological Outcomes: Study Summary

Previous related pageVitamin D, Gene Regulation and Physiological Outcomes: Full Evidence ReviewNext related pageVitamin D Receptor Activation and Co-Regulator Recruitment: Study Summary
Study at a glance

What question did the studies ask?

Researchers asked how vitamin D-related changes in gene activity connect with tissue and whole-body outcomes. Gene activity produces RNA messages used by cells. A changed message does not automatically mean that a tissue works better. Most experiments used cells or animals; one included a year-long trial in older adults.

What did the researchers find?

Some mouse experiments linked receptor or gene-regulatory changes with calcium absorption, blood pressure, glucose handling or tissue scarring. An experiment using deliberately toxic injected vitamin D3 in mice found harmful mineral deposits. Another experiment found a large gene-response change without a clear resting mineral problem. Changes in nerve-insulating myelin structure or muscle fat did not establish better nerve performance or strength. In the human trial, vitamin D3 raised blood vitamin D but did not produce a clear gene response in the measured blood cells.

What does this mean?

The findings depended on the intervention, tissue and conditions. Removing a receptor, changing its partners, giving active hormone and taking vitamin D3 are different interventions. A measured outcome does not prove that one gene or protein contact caused it. Animal findings do not establish a general human treatment benefit or a personal dose.

Read the full article below ↓

Vitamin D-related changes in gene activity can accompany changes in calcium balance, metabolism and tissue structure. The strength of the connection depends on what researchers changed and what they measured. Some experiments found recovery, some found harm, and others found no clear change. For the detailed evidence, read Vitamin D, Gene Regulation and Physiological Outcomes: Full Evidence Review.

What question did the studies ask?

Genes contain information used by cells. Transcription makes RNA messages from genes; a changed message does not automatically mean a changed protein or better tissue performance. Vitamin D and Gene Expression explains gene activity. The vitamin D receptor is a protein that can help regulate it, as described in Vitamin D Receptors.

Researchers studied receptor restoration, altered regulatory DNA, changed receptor partners and different treatments. Vitamin D and Transcription Factors introduces those cooperating proteins, while Vitamin D and Nuclear Receptors places the receptor in its wider family. Most studies used cells or animals. Active vitamin D hormone, laboratory-made receptor activators and oral vitamin D3 are different exposures.

Calcium balance and receptor changes

Restoring a receptor mainly in the intestine of otherwise receptor-deficient mice recovered measured calcium absorption, growth and blood calcium and parathyroid hormone. This hormone helps regulate calcium balance. Some gene responses differed from the comparison animals, and hair loss remained. The main comparators retained one working receptor-gene copy; some restored receptor signal also appeared in kidney. The experiment tested what restoration could accomplish, rather than what deleting the receptor only in intestine would prevent. It did not isolate gene transcription as the only mechanism. [1]

A second study changed DNA regions controlling a vitamin D breakdown gene. The induced gene response fell substantially, but young mice showed no clear resting difference in blood calcium, phosphate, two measured regulatory hormones or weight. Some vitamin D metabolites changed. The DNA changes also affected a neighbouring regulatory site. Compensation and the tested age and conditions limit any claim that the animals were physiologically identical. [2]

In another mouse study, a receptor missing an activation region could not recruit the tested activating proteins normally, yet retained other interactions. Those mice had more severe mineral and bone problems than mice with no receptor. A mineral-rich diet helped the receptor-null mice more than the altered-receptor mice. Changes restricted to selected bone-related cell groups did not reproduce the full problem, although the groups were broad and one deletion was incomplete. This points beyond bone cells alone; it does not prove that one suppressed transport gene caused the systemic problem or that all remaining actions were independent of hormone binding. [3]

Blood pressure and metabolism

Mice lacking the receptor had increased renin and angiotensin II, components of a blood-pressure control system, with raised pressure. An inhibitor reduced the pressure difference. Active vitamin D also lowered renin gene activity in engineered kidney-derived cells. Calcium controls strengthened the connection, but other hormone changes and whole-body receptor loss remained alternative contributors. The study did not identify a particular suppressive DNA element or prove the entire mechanism inside the animal. It does not show that supplements treat human hypertension. [4]

Mixed liver cells from unborn mouse offspring of vitamin D-deficient mothers transferred altered insulin responses to other mice kept vitamin-D-sufficient. The mixture included blood-forming stem cells; they were not purified. Insulin regulates glucose use. Changing a downstream regulatory programme or a selected small RNA supported parts of the metabolic pathway. The study did not establish a physical receptor: JARID2 complex or identify one DNA mark as the cause. Its observational human samples and experiments on mouse fat cells did not establish prevention of diabetes in children. [5]

Another study combined a laboratory-made receptor activator with a substance inhibiting a protein called BRD9. The combination changed gene-regulating protein groups and improved selected mouse glucose, insulin and pancreatic-cell measures. Results depended on the model and combination; single treatments were sometimes ineffective. Other tissues or drug effects could contribute, and one protein contact was not isolated as the sole cause. Human cells studied outside the body were not a treatment trial. No lasting effect after stopping treatment or ordinary vitamin D3 benefit was established. [6]

Kidney, liver and blood-vessel outcomes

A kidney study combined direct binding between isolated protein parts with tests of reduced gene activation and mouse injury. Experimental ligands reduced scarring, and a longer experiment improved a kidney-function marker. This remained a gene-regulation mechanism, even though it differed from the usual receptor activation route. Calcium changes and animal-model limits prevent claims of completely calcium-neutral safety or established human kidney treatment. [7]

The liver study found a different pattern of receptor and regulatory-protein behaviour at DNA, linked with less scarring in a mouse injury model. It did not demonstrate the same isolated-protein binding mechanism as the kidney study, prove every assigned gene caused the outcome, or measure improved clinical liver function. It shared investigators with the pancreatic study, so the two were not independent teams confirming one identical mechanism. [8]

A blood-vessel study deliberately used toxic injected vitamin D3 in mice and produced harmful mineral deposits. Changing the RUNX2 regulator protected against deposits even when blood calcium remained high. Removing the vitamin D receptor also altered calcium, complicating the interpretation. The experiments did not isolate one protein contact or establish cardiovascular benefit. They do not predict harm from ordinary oral intake. [9]

Local structure has its own limits

Rat-cell and brain-slice experiments linked receptor function with myelin-associated structure. Myelin insulates nerve fibres. Added active hormone initially gave no extra cell-maturation response under ordinary serum conditions; a response appeared after different culture conditions. The work did not isolate one receptor-partner contact or measure nerve conduction, behaviour or human repair. Local structure was not a whole-animal neurological benefit. [10]

Mouse muscle experiments linked receptor signalling in immature cells with less fat-cell formation. Deficiency-related fat accumulation differed between old and young mice. A regulatory protein changed without its RNA changing, so transcriptional suppression of that gene was not demonstrated. Neither a rescue test of that regulator nor a physical receptor complex established the proposed mechanism. Muscle force was not measured, and the human muscle observations lacked vitamin D blood measurements. Tissue composition cannot be called improved strength. [11]

A receptor unable to bind hormone normally still restored selected hair-cycle outcomes in genetically altered mice. That does not make every skin function independent of hormone binding, or show that one partner interaction caused the rescue. Engineered expression and the whole-body receptor-deficient background limit interpretation. Receptor loss is different from low vitamin D supply. [12]

What did the human trial add?

A year-long randomized trial in older adults compared oral vitamin D3 with an inactive treatment. Blood vitamin D rose, but the primary controlled analysis found no clear whole-blood gene response or convincing change in selected inflammatory signals. One late sample of mixed blood cells cannot exclude earlier, smaller or other-tissue effects. It also cannot establish that every animal-study physiological outcome is absent in people. [13]

The studies connect particular regulatory changes with particular outcomes; they do not support one uniformly beneficial response. Molecular findings, local structure, whole-body physiology and human treatment benefit require different evidence. These findings provide no personal treatment dose.

Scientific sources

[1] Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice. Xue Y, Fleet JC. Gastroenterology. 2009;136(4):1317-27, e1-2. DOI 10.1053/j.gastro.2008.12.051; PMID 19254681; PMCID PMC2695717.

[2] In Vivo Contribution of Cyp24a1 Promoter Vitamin D Response Elements. Meyer MB, Lee SM, Towne JM, Cichanski SR, Kaufmann M, Jones G, Pike JW. Endocrinology. 2024;165(11):bqae134. DOI 10.1210/endocr/bqae134; PMID 39363152; PMCID PMC11487884.

[3] Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose. Doms S, Verlinden L, Janssens I, Vanhevel J, Eerlings R, Houtman R, Kato S, Mathieu C, Decallonne B, Carmeliet G, Verstuyf A. Bone research. 2024;12(1):44. DOI 10.1038/s41413-024-00343-7; PMID 39164247; PMCID PMC11335873.

[4] 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. The Journal of clinical investigation. 2002;110(2):229-38. DOI 10.1172/JCI15219; PMID 12122115; PMCID PMC151055.

[5] Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes. Oh J, Riek AE, Bauerle KT, Dusso A, McNerney KP, Barve RA, Darwech I, Sprague JE, Moynihan C, Zhang RM, Kutz G, Wang T, Xing X, Li D, Mrad M, Wigge NM, Castelblanco E, Collin A, Bambouskova M, Head RD, Sands MS, Bernal-Mizrachi C. Nature communications. 2023;14(1):3278. DOI 10.1038/s41467-023-38849-z; PMID 37311757; PMCID PMC10264405.

[6] Vitamin D Switches BAF Complexes to Protect β Cells. Wei Z, Yoshihara E, He N, Hah N, Fan W, Pinto AFM, Huddy T, Wang Y, Ross B, Estepa G, Dai Y, Ding N, Sherman MH, Fang S, Zhao X, Liddle C, Atkins AR, Yu RT, Downes M, Evans RM. Cell. 2018;173(5):1135-1149.e15. DOI 10.1016/j.cell.2018.04.013; PMID 29754817; PMCID PMC5987229.

[7] A nonclassical vitamin D receptor pathway suppresses renal fibrosis. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. The Journal of clinical investigation. 2013;123(11):4579-4594. DOI 10.1172/jci67804; PMID 24135137; PMCID PMC3809783.

[8] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. Cell. 2013;153(3):601-613. DOI 10.1016/j.cell.2013.03.028; PMID 23622244; PMCID PMC3673534.

[9] Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification. Han MS, Che X, Cho GH, Park HR, Lim KE, Park NR, Jin JS, Jung YK, Jeong JH, Lee IK, Kato S, Choi JY. PloS one. 2013;8(12):e83584. DOI 10.1371/journal.pone.0083584; PMID 24349534; PMCID PMC3861528.

[10] Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation. de la Fuente AG, Errea O, van Wijngaarden P, Gonzalez GA, Kerninon C, Jarjour AA, Lewis HJ, Jones CA, Nait-Oumesmar B, Zhao C, Huang JK, ffrench-Constant C, Franklin RJ. The Journal of cell biology. 2015;211(5):975-985. DOI 10.1083/jcb.201505119; PMID 26644513; PMCID PMC4674280.

[11] Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle. Hosoyama T, Kawai-Takaishi M, Iida H, Yamamoto Y, Nakamichi Y, Watanabe T, Takemura M, Kato S, Uezumi A, Matsui Y. Journal of cachexia, sarcopenia and muscle. 2024;15(3):907-918. DOI 10.1002/jcsm.13448; PMID 38533539; PMCID PMC11154772.

[12] Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, Demay MB. Molecular endocrinology (Baltimore, Md.). 2005;19(4):855-862. DOI 10.1210/me.2004-0415; PMID 15591533.

[13] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial. Berlanga-Taylor AJ, Plant K, Dahl A, Lau E, Hill M, Sims D, Heger A, Emberson J, Armitage J, Clarke R, Knight JC. EBioMedicine. 2018;31:133-142. DOI 10.1016/j.ebiom.2018.04.010; PMID 29685792; PMCID PMC6013786.

Related reading

Original sources

Source

In Vivo Contribution of Cyp24a1 Promoter Vitamin D Response Elements.

Published in Meyer MB, Lee SM, Towne JM, Cichanski SR, Kaufmann M, Jones G, Pike JW. Endocrinology (2024).

Publication details

[2] In Vivo Contribution of Cyp24a1 Promoter Vitamin D Response Elements. Meyer MB, Lee SM, Towne JM, Cichanski SR, Kaufmann M, Jones G, Pike JW. Endocrinology. 2024;165(11):bqae134. DOI 10.1210/endocr/bqae134; PMID 39363152; PMCID PMC11487884.

Read more →
Source

Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose.

[3] Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose.

Publication details

[3] Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose. Doms S, Verlinden L, Janssens I, Vanhevel J, Eerlings R, Houtman R, Kato S, Mathieu C, Decallonne B, Carmeliet G, Verstuyf A. Bone research. 2024;12(1):44. DOI 10.1038/s41413-024-00343-7; PMID 39164247; PMCID PMC11335873.

Read more →
Source

Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes

Environmental factors may alter the fetal genome to cause metabolic diseases.

Publication details

[5] Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes. Oh J, Riek AE, Bauerle KT, Dusso A, McNerney KP, Barve RA, Darwech I, Sprague JE, Moynihan C, Zhang RM, Kutz G, Wang T, Xing X, Li D, Mrad M, Wigge NM, Castelblanco E, Collin A, Bambouskova M, Head RD, Sands MS, Bernal-Mizrachi C. Nature communications. 2023;14(1):3278. DOI 10.1038/s41467-023-38849-z; PMID 37311757; PMCID PMC10264405.

Read more →
Source

Vitamin D Switches BAF Complexes to Protect β Cells.

[6] Vitamin D Switches BAF Complexes to Protect β Cells.

Publication details

[6] Vitamin D Switches BAF Complexes to Protect β Cells. Wei Z, Yoshihara E, He N, Hah N, Fan W, Pinto AFM, Huddy T, Wang Y, Ross B, Estepa G, Dai Y, Ding N, Sherman MH, Fang S, Zhao X, Liddle C, Atkins AR, Yu RT, Downes M, Evans RM. Cell. 2018;173(5):1135-1149.e15. DOI 10.1016/j.cell.2018.04.013; PMID 29754817; PMCID PMC5987229.

Read more →
Source

A nonclassical vitamin D receptor pathway suppresses renal fibrosis.

[7] A nonclassical vitamin D receptor pathway suppresses renal fibrosis.

Publication details

[7] A nonclassical vitamin D receptor pathway suppresses renal fibrosis. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. The Journal of clinical investigation. 2013;123(11):4579-4594. DOI 10.1172/jci67804; PMID 24135137; PMCID PMC3809783.

Read more →
Source

A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.

[8] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.

Publication details

[8] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. Cell. 2013;153(3):601-613. DOI 10.1016/j.cell.2013.03.028; PMID 23622244; PMCID PMC3673534.

Read more →
Source

Functional Cooperation between Vitamin D Receptor and Runx2 in Vitamin D-Induced Vascular Calcification

The transdifferentiation of vascular smooth muscle cells (VSMCs) into osteoblast-like cells has been implicated in the context of vascular calcification.

Publication details

[9] Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification. Han MS, Che X, Cho GH, Park HR, Lim KE, Park NR, Jin JS, Jung YK, Jeong JH, Lee IK, Kato S, Choi JY. PloS one. 2013;8(12):e83584. DOI 10.1371/journal.pone.0083584; PMID 24349534; PMCID PMC3861528.

Read more →
Source

Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.

[10] Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.

Publication details

[10] Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation. de la Fuente AG, Errea O, van Wijngaarden P, Gonzalez GA, Kerninon C, Jarjour AA, Lewis HJ, Jones CA, Nait-Oumesmar B, Zhao C, Huang JK, ffrench-Constant C, Franklin RJ. The Journal of cell biology. 2015;211(5):975-985. DOI 10.1083/jcb.201505119; PMID 26644513; PMCID PMC4674280.

Read more →
Source

Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle.

[11] Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle.

Publication details

[11] Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle. Hosoyama T, Kawai-Takaishi M, Iida H, Yamamoto Y, Nakamichi Y, Watanabe T, Takemura M, Kato S, Uezumi A, Matsui Y. Journal of cachexia, sarcopenia and muscle. 2024;15(3):907-918. DOI 10.1002/jcsm.13448; PMID 38533539; PMCID PMC11154772.

Read more →
Source

Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis.

Published in Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, Demay MB. Molecular endocrinology (Baltimore, Md.) (2005).

Publication details

[12] Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, Demay MB. Molecular endocrinology (Baltimore, Md.). 2005;19(4):855-862. DOI 10.1210/me.2004-0415; PMID 15591533.

Read more →
Source

Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.

[13] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.

Publication details

[13] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial. Berlanga-Taylor AJ, Plant K, Dahl A, Lau E, Hill M, Sims D, Heger A, Emberson J, Armitage J, Clarke R, Knight JC. EBioMedicine. 2018;31:133-142. DOI 10.1016/j.ebiom.2018.04.010; PMID 29685792; PMCID PMC6013786.

Read more →